Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for organ transplants and tissue regeneration
3.2.1.2 Advancements in bioprinting technologies
3.2.1.3 Increased biotechnology and pharmaceutical R&D investments
3.2.1.4 Growing demand for personalized medicines
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs associated with 3D bioprinting equipment and materials
3.2.2.2 Regulatory and ethical challenges associated with bioprinted tissues and organs
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Future market trends
3.6 Regulatory landscape
3.7 Technological landscape
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Component, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 3D bioprinters
5.3 Bioinks
5.4 Software
5.5 Consumables
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Clinical applications
6.2.1 Regenerative medicine
6.2.2 Orthopedic implants
6.2.3 Dental implants
6.2.4 Cosmetic surgery
6.3 Non-clinical applications
6.3.1 Drug discovery
6.3.2 Drug research
Chapter 7 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Inkjet bioprinting
7.3 Microextrusion bioprinting
7.4 Laser-assisted bioprinting
7.5 Magnetic levitation bioprinting
7.6 Stereolithography
Chapter 8 Market Estimates and Forecast, By Material, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hydrogels
8.3 Living cells
8.4 Extracellular matrices
8.5 Bioplastics
Chapter 9 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals
9.3 Academic and research institutes
9.4 Pharmaceutical and biotechnology companies
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Advanced Solutions Life Sciences, LLC
11.2 Allevi, Inc.
11.3 Aspect Biosystems Ltd.
11.4 BICO Group AB
11.5 Brinter
11.6 CollPlant Biotechnologies Ltd.
11.7 CYFUSE BIOMEDICAL K.K.
11.8 ENVISIONTEC US LLC
11.9 Inventia Life Science Pty Ltd.
11.10 Merck KGaA
11.11 Organovo Holdings, Inc.
11.12 Poietis
11.13 regenHU
11.14 Rokit Healthcare, Inc.
11.15 3D Systems Corporation
